In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.
第一作者:
Jennifer A,Leeds
第一单位:
Novartis Institutes for BioMedical Research, 4560 Horton Street, Emeryville, CA 94608, USA.
作者:
医学主题词
氨基糖苷类(Aminoglycosides);抗菌药(Anti-Bacterial Agents);细胞壁(Cell Wall);DNA突变分析(DNA Mutational Analysis);DNA, 细菌(DNA, Bacterial);指导DNA的RNA聚合酶类(DNA-Directed RNA Polymerases);抗药性, 细菌(Drug Resistance, Bacterial);基因组, 细菌(Genome, Bacterial);人类(Humans);微生物敏感性试验(Microbial Sensitivity Tests);突变(Mutation);遗传选择(Selection, Genetic);序列分析, DNA(Sequence Analysis, DNA);连续传代(Serial Passage);噻唑类(Thiazoles);万古霉素(Vancomycin)
DOI
10.1093/jac/dkt302
PMID
23887866
发布时间
2023-12-13
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



